Carnitine metabolites and cognitive improvement in patients with schizophrenia treated with olanzapine: a prospective longitudinal study

• Autors principals: Lei Zhao (Autor), Hua Liu (Autor), Wenjuan Wang (Autor), Youping Wang (Autor), Meihong Xiu (Autor), Shuyun Li (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Objective: Cognitive impairment is one of the core symptoms of schizophrenia, which is stable and lifelong. L-carnitine has been shown to improve cognitive function and decrease the rate of cognitive deterioration in patients with Alzheimer's disease. However, it remains unclear regarding the r...